Sangamo Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Sangamo Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Sangamo Therapeutics Inc Strategy Report
- Understand Sangamo Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Sangamo Therapeutics Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Sangamo Therapeutics Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 15 Mar 2019 | Lorem |
| Sangamo’s Phase I SB-913 study in MPS II unlikely to see neurological disease changes but somatic manifestations have better chance, experts say | 17 Oct 2018 | Mina Moawad |
| Sangamo’s gene therapy clinical development less appealing if hemophilia A trial repeats preclinical immunosuppression strategy, experts say | 16 Mar 2018 | Alaric DeArment |
| Sangamo’s next trial of MPS-1 gene therapy raises design challenges around patient variability, CNS measures and control arm -- experts | 29 Jan 2018 | Fiona Barry,;Hamish McDougall |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward